2025
SJR Q1
JCR Q1 · 4,3
14 eşleşen makale
SCIE
Dergi ayrıntısı
Wound Repair and Regeneration
- Yayıncı
- Wiley-Blackwell Publishing Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
106719271524475X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,859
- Quartile Q1
- H-Index 143
- Atıf/yayın 4,15
- Doküman (3y) 223
- Atıf (3y) 905
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,3
- 5Y JIF 4,2
- JCI 1,15
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Dermatology Q1
- Surgery Q1
Alanlar
- Medicine
WoS kategorileri
- Cell Biology | Dermatology | Medicine, Research & Experimental | Surgery
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,859 | 4,3 | 4,2 | 1,15 | Q1 | 143 |
| 2024 | Q1 | Q1 | 0,776 | 3,4 | 4 | 1,05 | Q1 | 138 |
| 2023 | Q1 | Q1 | 0,802 | 3,8 | 4 | 0,99 | Q1 | 138 |
| 2022 | Q1 | Q2 | 0,737 | 2,9 | 3,7 | 0,87 | Q2 | 138 |
| 2021 | Q2 | Q2 | 0,659 | 3,4 | 4,2 | 0,76 | Q2 | 138 |
| 2020 | Q1 | Q1 | 0,847 | 3,6 | 4,5 | 0,92 | Q2 | 138 |
| 2019 | Q1 | Q2 | 0,974 | 2,5 | 3,7 | 1 | Q1 | 138 |
| 2018 | — | Q2 | — | 2,9 | 3,5 | 1,03 | Q1 | — |
| 2017 | Q1 | Q1 | 1,279 | 3 | 3,4 | 1,15 | Q1 | 138 |
| 2016 | Q1 | Q1 | 1,23 | 3 | 3,4 | — | — | 138 |
| 2015 | Q1 | Q1 | 1,286 | 2,6 | 3,2 | — | — | 138 |
| 2014 | Q1 | Q1 | 1,234 | 2,7 | 3,4 | — | — | 138 |
| 2013 | Q1 | Q1 | 1,098 | 2,8 | 3,8 | — | — | 138 |
| 2012 | Q1 | Q1 | 1,507 | 2,8 | 3,8 | — | — | 138 |
| 2011 | Q1 | Q1 | 1,588 | 2,9 | 3,4 | — | — | 138 |
| 2010 | Q1 | Q1 | 1,425 | 3,4 | 3,3 | — | — | 138 |
| 2009 | — | Q1 | — | 2,8 | 2,8 | — | — | — |
| 2008 | — | Q2 | — | 2,2 | 2,6 | — | — | — |
| 2007 | — | Q1 | — | 2,4 | 2,7 | — | — | — |
| 2006 | — | Q1 | — | 2,2 | — | — | — | — |
| 2005 | — | Q1 | — | 2,2 | — | — | — | — |
| 2004 | — | Q1 | — | 2 | — | — | — | — |
| 2003 | — | Q1 | — | 2,1 | — | — | — | — |
| 2002 | — | Q1 | — | 1,8 | — | — | — | — |
| 2001 | — | Q1 | — | 2,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q1 | 94/207 |
| 2025 | DERMATOLOGY | SCIE | Q1 | Q1 | 14/99 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 64/191 |
| 2025 | SURGERY | SCIE | Q1 | Q1 | 28/321 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q2 | 107/204 |
| 2024 | DERMATOLOGY | SCIE | Q1 | Q1 | 20/96 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 75/195 |
| 2024 | SURGERY | SCIE | Q1 | Q1 | 41/314 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q2 | 96/205 |
| 2023 | DERMATOLOGY | SCIE | Q1 | Q2 | 15/94 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 67/189 |
| 2023 | SURGERY | SCIE | Q1 | Q1 | 27/292 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q2 | 137/191 |
| 2022 | DERMATOLOGY | SCIE | Q2 | Q2 | 25/70 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 89/136 |
| 2022 | SURGERY | SCIE | Q2 | Q2 | 63/213 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q2 | 138/195 |
| 2021 | DERMATOLOGY | SCIE | Q2 | Q2 | 23/69 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 88/139 |
| 2021 | SURGERY | SCIE | Q2 | Q2 | 62/213 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q2 | 132/195 |
| 2020 | DERMATOLOGY | SCIE | Q2 | Q2 | 20/69 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 77/140 |
| 2020 | SURGERY | SCIE | Q1 | Q2 | 51/211 |
| 2019 | CELL BIOLOGY | SCIE | Q3 | Q2 | 143/195 |
| 2019 | DERMATOLOGY | SCIE | Q2 | Q2 | 28/68 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 81/139 |
| 2019 | SURGERY | SCIE | Q2 | Q1 | 70/210 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q2 | 125/193 |
| 2018 | DERMATOLOGY | SCIE | Q2 | Q2 | 20/66 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 66/136 |
| 2018 | SURGERY | SCIE | Q2 | Q1 | 55/203 |
| 2017 | CELL BIOLOGY | SCIE | Q3 | Q2 | 113/190 |
| 2017 | DERMATOLOGY | SCIE | Q1 | Q1 | 14/64 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 60/133 |
| 2017 | SURGERY | SCIE | Q1 | Q1 | 43/200 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 105/190 |
| 2016 | DERMATOLOGY | SCIE | Q1 | — | 10/63 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 42/128 |
| 2016 | SURGERY | SCIE | Q1 | — | 42/197 |
| 2015 | CELL BIOLOGY | SCIE | Q3 | — | 110/187 |
| 2015 | DERMATOLOGY | SCIE | Q1 | — | 12/61 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 56/124 |
| 2015 | SURGERY | SCIE | Q1 | — | 50/200 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 114/184 |
| 2014 | DERMATOLOGY | SCIE | Q1 | — | 12/63 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 51/123 |
| 2014 | SURGERY | SCIE | Q1 | — | 43/198 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 114/185 |
| 2013 | DERMATOLOGY | SCIE | Q1 | — | 11/61 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 48/124 |
| 2013 | SURGERY | SCIE | Q1 | — | 38/204 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 109/185 |
| 2012 | DERMATOLOGY | SCIE | Q1 | — | 11/59 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 50/121 |
| 2012 | SURGERY | SCIE | Q1 | — | 28/199 |
| 2011 | CELL BIOLOGY | SCIE | Q3 | — | 100/181 |
| 2011 | DERMATOLOGY | SCIE | Q1 | — | 13/58 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 40/112 |
| 2011 | SURGERY | SCIE | Q1 | — | 27/199 |
| 2010 | CELL BIOLOGY | SCIE | Q2 | — | 87/178 |
| 2010 | DERMATOLOGY | SCIE | Q1 | — | 9/55 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 28/106 |
| 2010 | SURGERY | SCIE | Q1 | — | 14/188 |
| 2009 | CELL BIOLOGY | SCIE | Q3 | — | 92/162 |
| 2009 | DERMATOLOGY | SCIE | Q1 | — | 12/48 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/93 |
| 2009 | SURGERY | SCIE | Q1 | — | 25/167 |
| 2008 | CELL BIOLOGY | SCIE | Q3 | — | 109/157 |
| 2008 | DERMATOLOGY | SCIE | Q2 | — | 15/43 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 42/83 |
| 2008 | SURGERY | SCIE | Q2 | — | 41/148 |
| 2007 | CELL BIOLOGY | SCIE | Q3 | — | 95/156 |
| 2007 | DERMATOLOGY | SCIE | Q1 | — | 9/41 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/81 |
| 2007 | SURGERY | SCIE | Q1 | — | 23/139 |
| 2006 | CELL BIOLOGY | SCIE | Q3 | — | 95/156 |
| 2006 | DERMATOLOGY | SCIE | Q2 | — | 10/39 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/76 |
| 2006 | SURGERY | SCIE | Q1 | — | 25/137 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 85/153 |
| 2005 | DERMATOLOGY | SCIE | Q1 | — | 8/39 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/72 |
| 2005 | SURGERY | SCIE | Q1 | — | 26/139 |
| 2004 | CELL BIOLOGY | SCIE | Q3 | — | 96/155 |
| 2004 | DERMATOLOGY | SCIE | Q1 | — | 6/38 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 30/71 |
| 2004 | SURGERY | SCIE | Q1 | — | 27/139 |
| 2003 | CELL BIOLOGY | SCIE | Q3 | — | 91/156 |
| 2003 | DERMATOLOGY | SCIE | Q1 | — | 7/38 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 29/72 |
| 2003 | SURGERY | SCIE | Q1 | — | 24/141 |
| 2002 | CELL BIOLOGY | SCIE | Q3 | — | 92/153 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q1 | — | 9/40 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 35/74 |
| 2002 | SURGERY | SCIE | Q1 | — | 32/141 |
| 2001 | CELL BIOLOGY | SCIE | Q2 | — | 61/147 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q1 | — | 4/38 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 20/75 |
| 2001 | SURGERY | SCIE | Q1 | — | 15/139 |